Eli Lilly to target cancer drug developers for deals

Eli Lilly and Co will target cancer drug developers for deals, Chief Executive Officer Dave Ricks said on a post-earnings conference call on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news